CoChat

An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection

Open access
Conzelmann, Carina, Gilg, Andrea, Groß, Rüdiger, Schütz, Desiree, Preising, Nico, Ständker, Ludger, Jahrsdörfer, Bernd, Schrezenmeier, Hubert, Sparrer, Konstantin M.J., Stamminger, Thomas, Stenger, Steffen, Münch, Jan, Müller, Janis A. · 2020 · Antiviral Research
Cited by 36

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Abstract SARS-CoV-2 is a novel pandemic coronavirus that caused a global health and economic crisis. The development of efficient drugs and vaccines against COVID-19 requires detailed knowledge about SARS-CoV-2 biology. Several techniques to detect SARS-CoV-2 infection have been established, mainly based on counting infected cells by staining plaques or foci, or by quantifying the viral genome by PCR. These methods are laborious, time-consuming and expensive and therefore not suitable for a high sample throughput or rapid diagnostics. We here report a novel enzyme-based immunodetection assay that directly quantifies the amount of de novo synthesized viral spike protein within fixed and permeabilized cells. This in-cell ELISA enables a rapid and quantitative detection of SARS-CoV-2 infection in microtiter format, regardless of the virus isolate or target cell culture. It follows the established method of performing ELISA assays and does not require expensive instrumentation. Utilization of the in-cell ELISA allows to e.g. determine TCID 50 of virus stocks, antiviral efficiencies (IC 50 values) of drugs or neutralizing activity of sera. Thus, the in-cell spike ELISA represents a promising alternative to study SARS-CoV-2 infection and inhibition and may facilitate future research. Highlights Determination of SARS-CoV-2 infection by enzymatically quantifying the expression of viral spike protein in bulk cell cultures Targeting a highly conserved region in the S2 subunit of the S protein allows broad detection of several SARS-CoV-2 isolates in different cell lines Screening of antivirals in microtiter format and determining the antiviral activity as inhibitory concentrations 50 (IC 50 )

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.antiviral.2020.104882

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 36

Metadata

Authors
Conzelmann, C., Gilg, A., Groß, R., Schütz, D., Preising, N., Ständker, L., Jahrsdörfer, B., Schrezenmeier, H., Sparrer, K. M. J., Stamminger, T., Stenger, S., Münch, J., & Müller, J. A.
Venue
Antiviral Research
Publisher
Elsevier BV
Published
2020-09
Volume
181
Pages
104882
ISSN
0166-3542 (ISSN-L)
OpenAlex
W3045983745
Cited by
36
References
8
FWCI
0.91
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. https://app.cochat.ai/papers/10.1016/j.antiviral.2020.104882
The paper
Conzelmann, C., Gilg, A., Groß, R., Schütz, D., Preising, N., Ständker, L., Jahrsdörfer, B., Schrezenmeier, H., Sparrer, K. M. J., Stamminger, T., Stenger, S., Münch, J., & Müller, J. A. (2020). An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antiviral Research. https://doi.org/10.1016/j.antiviral.2020.104882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.